Supplementary material: Topical vs Systemic Corticosteroids for DRESS Syndrome: Real-World Outcomes from a Multi-Center Retrospective Cohort
Published: 20 April 2026| Version 1 | DOI: 10.17632/5f4np6sk95.1
Contributor:
Ingrid SalciccioliDescription
Supplemental table 1: Culprit drug classes in patients with single-agent and multiple-agent DRESS, stratified by treatment group. Supplemental Table 2: Escalation to systemic corticosteroid by topical corticosteroid potency, dichotomized as very high and high potency (Class I–II) vs medium to very low potency (Class III+)
Files
Categories
Dermatology, Drug Adverse Reactions